UCLH has a comprehensive lung cancer service and we see both local secondary referrals and tertiary referrals from across the UK.
Our results in the National Lung Cancer Audit are outstanding.
We are the Cancer Research UK’s Lung Cancer Centre of Excellence, together with Manchester, in recognition of our outstanding lung cancer service, expertise and ambition in lung cancer research.
We treat patients with lung cancer, thymoma, mesothelioma, tracheal cancers and other rare lung tumours.
We run a rapid diagnostics clinic in the UCLH Macmillan Cancer Centre, which offers rapid diagnostic tests including CT, MRI and PET CT/MR for patients with suspected lung cancer.
UCLH nursing and radiography staff also provide the NHS Targeted Lung Health Check Programme in north central London. Targeted Lung Health Checks are offered by invitation to people aged 55 to 74 who are at a greater risk of developing lung cancer. After a conversation with a health professional, if needed, there will be a quick and simple scan of the lungs.
A Targeted Lung Health Check can identify signs of cancer at an early stage when it is much more treatable - saving lives. Find out more about the programme in north central London.
Other contact information
Telephone: 020 3447 9091
University College Hospital
3rd Floor Central
250 Euston Road
London, NW1 2PG
Other referral information
- Please provide the patient’s full demographic details, including ethnic origin & NHS Number.
- Please state if an interpreter is required; if so, what language is needed.
- Transport required for first appointments must be booked by GP. Please indicate where patients have a disability.
Relevant NHS e-Referral Service (formerly Choose and Book referrals) Terms:
- Suspected or confirmed lung cancer patients will be seen within two weeks in SJ41P, PJG1P, NN11P, NN11R.1A or PJG8M
- Exclusions: Children
Referrals for suspected lung cancer are seen within two weeks.
Cancer Waiting Times
Cancer Services, 2nd floor North
250 Euston Road
London NW1 2PG
All of our thoracic surgery is performed at the University College Hospital at Westmoreland Street, where we provide dedicated specialist care by leading cardiothoracic surgeons.
At UCLH, we have a bronchoscopy suite with state-of-the-art equipment and technology used to deliver minimally invasive endoscopic techniques to diagnose and treat lung cancer.
We routinely perform advanced diagnostic techniques such as endobronchial ultrasound (EBUS), navigational and image-guided bronchoscopy – more than 90% of these are performed on an outpatient basis. We also run a pre-cancer surveillance programme for patients with suspicious changes in their airways using autofluorescence bronchoscopy – this uses autofluorescence light to detect premalignant lesions not usually seen with standard bronchoscopy.
We offer therapeutic endoscopic treatments to treat early tumours in the airway and patients presenting with an obstructed or narrowed airway, usually as a result of tumour blocking the tracheobronchial tree.
Interventional bronchoscopy treatments include:
- Endobronchial ablation using laser or argon plasma
- Cryotherapy using a freezing treatment to destroy tumours
- Photodynamic therapy uses light treatment to destroy cancers
- Brachytherapy delivers localised radiotherapy by placing radioactive material internally to treat cancers in the airway
- Airway stent placement used metal or silicone stents to provide support to the windpipe
Our service utilises clinical expertise set within an established academic environment, that offers patients cutting-edge technology to treat lung cancer.
We routinely use advanced modalities to treat lung cancer such as specialist scans incorporating tumour movement, PET to help define active disease, and CT and KV imaging during treatment to ensure accuracy and precision.
We offer 4DCT scanning, stereotactic radiotherapy, conformal treatment, IMRT (Intensity modulated Radiotherapy) and gated treatment delivery using coached breathing.
The goal of our highly skilled multidisciplinary radiotherapy team is to offer personalised, patient-centred care and support in a modern, friendly environment.
UCLH offers the latest anticancer therapies including immunotherapy.
We perform extensive molecular testing and next-generation sequencing on tumours to find a personalised treatment for every individual patient. Chemotherapy and immunotherapy are typically given as an intravenous infusion; this is delivered as an outpatient in the UCLH Macmillan Cancer Centre.
We are also able to offer novel treatments in research trials and our medical oncology team includes leaders of national research trials in lung cancer.
UCLH heads several national trials in genomics of lung cancer (Professor Charles Swanton), chemotherapeutics (Professor Siow Ming Lee and Dr Martin Forster), and early diagnosis and rapid diagnosis and staging of lung cancers (Professor Sam Janes, Dr Neal Navani & Dr Jeremy George).
Early detection and pre-invasive disease: UCLH has embarked on the largest lung cancer screening project in the UK (SUMMIT study). Patients with significant smoking histories are contacted through their GP surgery and offered a free lung health check and with consent will be offered a low dose CT scan, which has been demonstrated to be highly effective identifying early lung cancer. We also have one of the UK’s most comprehensive longitudinal surveillance programme for patients with premalignant changes in their airway.
Lung cancer genomics: Professor Charles Swanton leads research into lung cancer evolution and heterogeneity in order to understand how lung cancers develop, their response to treatment and mechanisms for drug resistance and treatment failure. TRAcking Cancer Evolution through therapy (TRACERx) is a landmark research project that is uncovering the mechanisms of cancer evolution with the hope that it will ultimately improve precision cancer medicine for patients with lung cancer.
Lung cancer clinical trials: UCLH has been world leading in conducting seminal clinical trials in lung cancer. As part of UCL, we have one the largest clinical trials units in the UK, conducting both early phase studies for novel treatments and large clinical trials in lung cancer.
If you are interested in taking part in our research, please talk to your medical consultant about this at your next appointment. They will know about the research studies happening at UCLH that you might be able to participate in.
We recognise that being diagnosed with cancer can be a difficult time. At the UCLH Macmillan Cancer Centre we have a number of support services for you and your family at this difficult time. Patients are supported throughout by a dedicated team specialist doctors and senior nurses and are given a direct contact of their nominated keyworker.
Specialist support is available from our team of lung cancer clinical nurse specialists.
Telephone: 0203 0447 2161
The Macmillan Information Centre
UCH Macmillan Cancer Centre
London WC1E 6AG
We also have a specialist enhanced supportive care team who help people stay well during treatment for lung cancer. It is a scheme designed to make sure patients have better access to specialists who help improve or resolve symptoms caused by cancer and also offer practical advice and support. You can ask any of your doctors or specialist nurse to refer you, or you can contact the team directly.
Telephone: 07973 627170 or 07583 047731